Trial Profile
A Phase II Study of Single Agent Clofarabine in Previously Untreated Older Adult Patients With Acute Myelogenous Leukemia (AML) for Whom Standard Induction Chemotherapy is Unlikely to be of Benefit.
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 03 Nov 2021
Price :
$35
*
At a glance
- Drugs Clofarabine (Primary)
- Indications Acute myeloid leukaemia
- Focus Therapeutic Use
- Acronyms CLASSIC-II
- 29 Dec 2010 Actual end date changed from Mar 2010 to May 2010 as reported by ClinicalTrials.gov.
- 29 Dec 2010 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 24 Nov 2009 M.D. Anderson Cancer Center reports actual start date (23 Oct 2006) and planned number of patients (109).